title: Verapamil synergistically enhances cytotoxicity of bortezomib in mantle cell lymphoma via induction of reactive oxygen species production.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Chen
authors.forename: Jorge
authors.initials: J
authors.lastname: Romaguera
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
authors.forename: Luis
authors.initials: L
authors.lastname: Fayad
authors.forename: Larry W
authors.initials: LW
authors.lastname: Kwak
authors.forename: Nami
authors.initials: N
authors.lastname: McCarty
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001897:Boronic Acids / Q000819:agonists / Q000494:pharmacology*; D000069286:Bortezomib; D004357:Drug Synergism; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000378:metabolism*; D008297:Male; D011719:Pyrazines / Q000819:agonists / Q000494:pharmacology*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000819:agonists / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D017382:Reactive Oxygen Species; D014665:Vasodilator Agents; D000069286:Bortezomib; D014700:Verapamil